Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Abraham

Showing results (501-510 of 509) with videos related to

Pageof 51
Sort By:
You have reached the last page of results.This site can display upto 509 results.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.
The Lancet. Oncology|December 13, 2021
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patientsChristina Yau, Marie Osdoit, Marieke van der Noordaa, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Nature Communications|December 3, 2017
The Kalanchoë genome provides insights into convergent evolution and building blocks of crassulacean acid metabolismXiaohan Yang, Rongbin Hu, Hengfu Yin, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
Journal of the National Cancer Institute|April 20, 2015
Identification of novel genetic markers of breast cancer survivalQi Guo, Marjanka K Schmidt, Peter Kraft, et al.
Science Translational Medicine|June 3, 2016
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart diseaseRobert A Scott, Daniel F Freitag, Li Li, et al.
Pageof 51

Showing results (501-510 of 509) with videos related to

Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 509 results.
Nature|April 8, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancerJean E Abraham, Karen Pinilla, Alimu Dayimu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRIFerdia A Gallagher, Ramona Woitek, Mary A McLean, et al.
NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.
The Lancet. Oncology|December 13, 2021
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patientsChristina Yau, Marie Osdoit, Marieke van der Noordaa, et al.
Nature Communications|May 13, 2025
Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trialJean E Abraham, Lenka Oplustil O'Connor, Louise Grybowicz, et al.
Nature Communications|December 3, 2017
The Kalanchoë genome provides insights into convergent evolution and building blocks of crassulacean acid metabolismXiaohan Yang, Rongbin Hu, Hengfu Yin, et al.
NPJ Breast Cancer|March 21, 2026
A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrenceChiea Chuen Khor, Whee Sze Ong, Elaine Hsuen Lim, et al.
Journal of the National Cancer Institute|April 20, 2015
Identification of novel genetic markers of breast cancer survivalQi Guo, Marjanka K Schmidt, Peter Kraft, et al.
Science Translational Medicine|June 3, 2016
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart diseaseRobert A Scott, Daniel F Freitag, Li Li, et al.
Pageof 51